Eurola, A., Ristimäki, A., Mustonen, H., Nurmi, A., Hagström, J., Haglund, C., & Seppänen, H. (2021). Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer. Nature Portfolio.
Style de citation Chicago (17e éd.)Eurola, Annika, Ari Ristimäki, Harri Mustonen, Anna-Maria Nurmi, Jaana Hagström, Caj Haglund, et Hanna Seppänen. Impact of Histological Response After Neoadjuvant Therapy on Podocalyxin as a Prognostic Marker in Pancreatic Cancer. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Eurola, Annika, et al. Impact of Histological Response After Neoadjuvant Therapy on Podocalyxin as a Prognostic Marker in Pancreatic Cancer. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.